Study guide
1.3 Benign Breast Conditions, Mastalgia & Fibrocystic Changes
CBCN Certified Breast Care Nurse Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction: The CBCN Exam
CBCN Exam Facts, 2026 Blueprint & Study Plan
2 Chapter 1: Breast Health, Examination & Benign Conditions (Care Continuum)
1.1 Breast Anatomy, Vascular Supply & Hormonal Physiology 1.2 Clinical Breast Examination & Breast Awareness Education 1.3 Benign Breast Conditions, Mastalgia & Fibrocystic Changes
3 Chapter 2: Screening, Breast Density & Special Populations (Care Continuum)
2.1 Screening Modalities, Breast Density & Pharmacologic Risk Reduction 2.2 Screening & Breast Health in Special Populations
4 Chapter 3: Cancer Risk Assessment & Genetics (Care Continuum)
3.1 Proliferative Lesions, Atypia & High-Risk Benign Pathology 3.2 Breast Cancer Risk Models (Gail, Tyrer-Cuzick, Claus, BRCAPRO) 3.3 Hereditary Cancer Syndromes & Genetic Evaluation
5 Chapter 4: Patient Navigation, Surveillance & Survivorship (Care Continuum)
4.1 Patient Navigation, Barriers to Care, Social Determinants & Interprofessional Collaboration 4.2 Survivorship Care Planning, Surveillance Intervals & Recurrence Monitoring 4.3 Secondary Prevention, Physical Activity, Nutrition & Wellness Guidance
6 Chapter 5: Carcinogenesis & Diagnostic Evaluation (Diagnosis and Staging)
5.1 Carcinogenesis: How Breast Cancer Develops and Spreads 5.2 Clinical Assessment, Diagnostic Imaging & BI-RADS Categorization 5.3 Breast Biopsy Modalities & Image-Guided Localization Techniques
7 Chapter 6: Pathology, Biomarkers & Genomic Testing (Diagnosis and Staging)
6.1 Histopathology: In Situ Carcinomas & Invasive Carcinoma Subtypes 6.2 Receptor Biomarkers (ER, PR, HER2, Ki-67) & Molecular Subtypes 6.3 Multigene Genomic Assays & Recurrence Risk Stratification
8 Chapter 7: Clinical & Pathologic Staging (Diagnosis and Staging)
7.1 AJCC TNM Staging System (Anatomic vs Prognostic Staging) 7.2 Staging Workup: When to Use MRI, CT, Bone Scan & PET
9 Chapter 8: Breast Surgery, Axillary Staging & Reconstruction (Treatment Modalities)
8.1 Breast-Conserving Surgery, Margin Standards & Mastectomy Techniques 8.2 Axillary Staging: Sentinel Lymph Node Biopsy vs. Axillary Dissection 8.3 Post-Mastectomy Reconstruction & Oncoplastic Surgery
10 Chapter 9: Radiation Therapy & Chemotherapy (Treatment Modalities)
9.1 Radiation Therapy: Whole Breast, Chest Wall, Regional Nodal & Partial Breast Irradiation 9.2 Neoadjuvant vs. Adjuvant Chemotherapy Principles & Standard Regimens
11 Chapter 10: Endocrine, HER2-Targeted & Novel Systemic Therapies (Treatment Modalities)
10.1 Endocrine Therapy: SERMs, Aromatase Inhibitors, Ovarian Suppression & SERDs 10.2 HER2-Targeted Monoclonal Antibodies, Antibody-Drug Conjugates & Kinase Inhibitors 10.3 CDK4/6 Inhibitors, PARP Inhibitors & Immune Checkpoint Blockade 10.4 Trop-2 Antibody-Drug Conjugates, PI3K/AKT/mTOR Inhibitors & New Oral SERDs
12 Chapter 11: Specific Conditions & Special Populations (Treatment Modalities)
11.1 Triple-Negative Breast Cancer: Treatment Considerations 11.2 HER2-Positive Breast Cancer: Treatment Considerations 11.3 Inflammatory Breast Cancer & Paget Disease of the Nipple 11.4 Phyllodes Tumors & Breast Angiosarcoma 11.5 Treatment Considerations for Special Populations
13 Chapter 12: Symptom Management & Supportive Care (Nursing Practice)
12.1 Acute Chemotherapy Toxicities, Supportive Regimens & Oncologic Emergencies 12.2 Lymphedema Pathophysiology, ISL Staging & Complete Decongestive Therapy (CDT) 12.3 Musculoskeletal Toxicities, Bone Health & Vasomotor/GSM Relief 12.4 Complementary & Integrative Modalities 12.5 Cancer Rehabilitation: Physical, Occupational & Pelvic Floor Therapy
14 Chapter 13: Oncologic Emergencies (Nursing Practice)
13.1 Oncologic Emergencies I: Spinal Cord Compression, Hypercalcemia, Tamponade & SVC Syndrome 13.2 Oncologic Emergencies II: Hypersensitivity & Anaphylaxis, Sepsis, Pleural Effusion & Thromboembolism
15 Chapter 14: Professional Practice, Clinical Trials & Self-Care (Nursing Practice)
14.1 Professional Practice: Guidelines, Ethics, Legislation, Outreach & Accreditation 14.2 Clinical Trials in Breast Oncology 14.3 Nurse Self-Care: Compassion Fatigue, Burnout, Moral Distress & Substance Use
16 Chapter 15: Psychosocial Dimensions of Care (Psychosocial Dimensions)
15.1 Psychosocial Distress, Coping, Grief & Palliative Care 15.2 Culture, Spirituality, Sexual & Gender Identity, Age & Healthcare Disparities 15.3 Family & Caregiver Dynamics 15.4 Altered Body Image 15.5 Reproductive & Sexual Health
1.3 Benign Breast Conditions, Mastalgia & Fibrocystic Changes
Key Takeaways Explain This Topic AI
Simple cysts represent fluid-filled dilations of obstructed TDLUs characterized on ultrasound by anechoic contents, imperceptible walls, and posterior acoustic enhancement; routine cytologic analysis of aspirate is indicated only for grossly bloody fluid.
Fat necrosis frequently mimics breast carcinoma both clinically (firm, fixed, irregular mass) and radiographically (spiculated density or lipid cyst with calcifications); definitive diagnosis requires biopsy demonstrating foamy lipid-laden macrophages and multinucleated foreign body giant cells.
Mondor disease is a benign, self-limited superficial thrombophlebitis of the thoracoepigastric or lateral thoracic veins presenting as a tender, palpable subcutaneous cord, treated conservatively with warm compresses and NSAIDs.
In lactational mastitis, the mother keeps breastfeeding on demand without over-pumping (ABM 2022), uses ice and ibuprofen, and adds anti-staphylococcal antibiotics when bacterial infection is likely, without interrupting infant feeding.
Cyclical mastalgia correlates with luteal phase hormonal fluctuations and resolves after menses, whereas non-cyclical mastalgia is focal, non-hormonal, and frequently originates from chest wall musculoskeletal structures such as costochondritis.
Last updated: September 2026
Benign Non-Proliferative Breast Lesions
Benign breast conditions encompass a wide clinical spectrum, ranging from physiological fluid collections to post-traumatic inflammatory processes and vascular disorders. Accurately distinguishing benign conditions from malignant neoplasia is a fundamental competency in breast care nursing.
Simple Breast Cysts
Breast cysts are microscopic or macroscopic fluid-filled structures originating from the terminal ductal lobular unit (TDLU). They represent the most common cause of a solitary or multiple discrete breast mass in women between the ages of 35 and 50 years, with prevalence declining dramatically following menopause unless exogenous hormone replacement therapy is initiated.
Pathophysiology : Terminal ductal outflow obstruction coupled with continuous fluid secretion from apocrine-metaplastic luminal epithelium leads to progressive acinar dilation. Cysts frequently expand and become acutely painful during the premenstrual luteal phase under progesterone stimulation.
Ultrasonographic Triad of a Simple Cyst : Ultrasonography is the definitive diagnostic modality. A simple cyst meets three strict sonographic criteria:
Completely anechoic interior (devoid of internal echoes).
Well-circumscribed, smooth, imperceptible thin outer margins.
Marked posterior acoustic enhancement (increased acoustic through-transmission behind the fluid collection).
Clinical Management & Fluid Triage : Simple, asymptomatic cysts identified incidentally on screening imaging are classified as BI-RADS 2 (benign) and require no intervention. When a cyst is painful, tense, or palpably bothersome, percutaneous fine-needle aspiration (FNA) is both diagnostic and therapeutic:
Normal non-bloody fluid : Typically appears straw-colored, clear yellow, cloudy, dark green, or murky brown. When typical fluid is aspirated and the mass completely resolves upon examination, the fluid is safely discarded without cytological evaluation , as routine cytology of non-bloody cyst fluid has an extraordinarily low diagnostic yield and high false-positive rate.
Indications for Cytology & Biopsy : Cytological evaluation and post-procedure imaging (mammography/ultrasound) are strictly indicated only if the aspirate is grossly bloody or if a palpable or sonographic mass fails to completely collapse following aspiration. Failure to collapse suggests an intracystic papillary lesion or necrotic malignancy requiring tissue biopsy.
Galactoceles
A galactocele is a benign milk-retention cyst that develops as a result of an obstructed lactiferous duct during lactation, abrupt weaning, or late pregnancy.
Clinical Presentation : Patients present with a smooth, discrete, non-tender, mobile, fluctuant mass, most commonly located in the subareolar or central parenchyma. They are typically painless unless complicated by secondary bacterial infection.
Diagnosis and Management : Diagnosis is confirmed via fine-needle aspiration, which yields thick, creamy, milky white fluid containing emulsified fat globules, protein, and lactose. In most instances, percutaneous aspiration is fully curative. Supportive nursing measures include reassurance, wearing a supportive non-underwire bra, and applying cold compresses. If secondary bacterial inoculation occurs, a galactocele can transition into a lactational breast abscess, requiring targeted antibiotic therapy.
Fat Necrosis
Fat necrosis is a benign non-suppurative inflammatory process occurring in breast adipose tissue, accounting for approximately 1% to 2% of all breast masses. It is clinically significant because it is the most notorious benign mimic of invasive breast carcinoma.
Etiology and Triggers : Fat necrosis develops secondary to disruption of the delicate blood supply to subcutaneous or interlobular adipocytes. Common clinical triggers include:
Blunt physical trauma (e.g. motor vehicle collision seatbelt impact or sports injury; reported in approximately 50% of cases).
Previous breast surgery (lumpectomy, reduction mammaplasty, reconstructive autologous flap transfer, or implant capsulotomy).
Previous stereotactic or core needle biopsy.
Post-adjuvant external beam radiation therapy.
Pathophysiology : Aseptic enzymatic digestion and saponification of neutral triglycerides release free fatty acids. These fatty acids complex with extracellular calcium salts to form radio-opaque calcium soaps. Over weeks to months, this triggers an intense histiocytic foreign body reaction, producing surrounding fibroblastic proliferation and dense cicatricial scarring.
The Clinical and Radiographic Dilemma :
Physical Examination : Fat necrosis often presents as a hard, poorly defined, irregular, immobile mass that can be tethered to the overlying skin, causing focal dermal retraction—indistinguishable on physical exam from locally advanced carcinoma.
Imaging : Mammography may reveal a classic radiolucent lipid cyst with thin peripheral rim (eggshell) calcifications. However, fat necrosis frequently manifests as an irregular, spiculated, dense soft-tissue mass with architectural distortion and pleomorphic microcalcifications, mimicking malignancy.
Histopathology & Nursing Management : Because imaging can be indeterminate (BI-RADS 4 or 5), core needle biopsy is often required for definitive diagnosis. Histological examination reveals lipid-filled foamy macrophages (histiocytes), multinucleated foreign body giant cells engulfing lipid droplets, hemosiderin-laden macrophages, and surrounding collagenous fibrosis. Once malignancy is excluded, management is strictly conservative; surgical excision is unnecessary unless the mass causes diagnostic discordance or persistent pain.
Hematomas and Seromas
Hematomas : Collections of blood within the parenchymal or subcutaneous space resulting from vascular disruption during surgical biopsy, breast trauma, or spontaneous hemorrhage in anticoagulated patients. Present as an acute, tender, tense mass with overlying ecchymosis. Managed conservatively with ice packs, analgesics, and compression; resolution typically occurs within 4 to 6 weeks. Aspiration is avoided initially to prevent introducing cutaneous bacteria into a fresh clot.
Seromas : Sterile serous exudate collections that accumulate in dead space created after surgical resection (such as lumpectomy or axillary lymph node dissection). Managed expectantly; percutaneous needle aspiration under aseptic technique is performed only if the collection is symptomatic, under painful tension, or compromises surgical incision healing.
Mondor Disease (Superficial Breast Thrombophlebitis)
Mondor disease is an uncommon, benign, self-limiting thrombophlebitis affecting the superficial veins of the breast and anterior chest wall.
Anatomical Substrates : Most frequently involves the lateral thoracic vein , the thoracoepigastric vein , or the superior epigastric vein .
Etiology : Precipitated by minor physical trauma, previous breast surgery, strenuous athletic exertion (e.g. rigorous weightlifting or tennis), tight restrictive undergarments, or local pressure. Occasionally, it can be the presenting sign of an underlying occult malignancy compressing venous return.
Clinical Presentation : Patients present with the abrupt onset of a tender, erythematous, subcutaneous "cord" or groove traversing vertically along the lateral or inferior breast toward the epigastrium or axilla. When the ipsilateral arm is elevated or the skin is gently stretched, a pathognomonic linear skin furrow or retracting groove appears.
Clinical and Nursing Management : Mondor disease is benign and self-limiting. Spontaneous recanalization and resolution occur within 4 to 8 weeks. Management focuses on:
Patient reassurance regarding the non-malignant nature of the cord.
Local application of warm, moist compresses for 15 to 20 minutes three times daily.
Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief.
Wearing a soft, supportive, non-restrictive bra.
Diagnostic mammography and targeted ultrasound should be completed once acute tenderness subsides to rule out an underlying mass compressing the venous lumen.